Does TNF-α blockade cause plaque rupture? [6]

Atherosclerosis

Volumn 173, Issue 1, 2004, Pages 149-

  Settergren, Magnus ^a   Tornvall, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; MATRIX METALLOPROTEINASE; METHOTREXATE; RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; BLOOD CLOT LYSIS; CLINICAL FEATURE; CORONARY STENT; DISEASE COURSE; EXERCISE TEST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LETTER; NONHUMAN; PATIENT INFORMATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ST SEGMENT ELEVATION;

EID: 1242283932     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.009     Document Type: Letter

References (4)

1. Mann D.L. Inflammatory mediators and the failing heart. Past, present and the foreseeable future. Circ. Res. 91:2002;988-998.
2. Coletta A.P., Clark A.L., Banarjee P., Cleland J.G.F. Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH. Eur. J. Heart Fail. 4:2002;559-561.
3. Chung E.S., Packer M., Lo K.H., Fasanmade A.A., Willerson J.T. Anti-TNF therapy against congestive heart failure investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation. 107(25):2003;3133-3140.
4. Sivasubramanian N., Coker M.L., Kurrelmeyer K.M., MacLellan W.R., DeMayo F.J., Spinale F.G.et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 104(14):2001;826-831.